Key points are not available for this paper at this time.
Lipid nanoparticles (LNPs) represent a promising platform for advanced drug and gene delivery, yet optimizing these particles for specific cargos and cell targets poses a complex, multifaceted challenge. Furthermore, there is a pressing need for a more comprehensive understanding of the underlying technology. Experimental studies are costly and often provide low-resolution information. Molecular dynamics (MD) simulations allow us to study these particles at a higher resolution, enhancing our understanding. However, studying these systems at atomic resolutions is both challenging and computationally expensive, as well as time-consuming. Coarse-grained (CG) models, such as Martini 3, are positioned as promising tools for studying LNPs. To enable CG-MD studies of LNPs, accurate and validated models of their components are needed. Here, we present a substantial extension of the Martini 3 library of lipids, covering the most important LNP components, including over a hundred of ionizable lipid (IL) models, along with natural occurring sterol models and PEGylated lipid models. We furthermore present initial protocols for screening fusion efficacy across different lipid formulations and for constructing whole LNPs at CG resolution, enabling future studies of these nanoparticles.
Building similarity graph...
Analyzing shared references across papers
Loading...
Lisbeth R. Kjølbye
AstraZeneca (Sweden)
Mariana Valério
Université Claude Bernard Lyon 1
Markéta Paloncýová
Regional Centre of Advanced Technologies and Materials
Centre National de la Recherche Scientifique
Inserm
University of Helsinki
Building similarity graph...
Analyzing shared references across papers
Loading...
Kjølbye et al. (Tue,) studied this question.
synapsesocial.com/papers/68e57799b6db643587517939 — DOI: https://doi.org/10.26434/chemrxiv-2024-bf4n8
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: